Warmly welcome you to visit Sinoway booth 5D94 at CPhI Milan 2024 from Oct. 8th to 10th. What Sinoway can do for you? 1 Up-to-date market information and recommendations based on the connection for 37years in pharmaceutical industry 2. High quality and moderate price of Key intermediates for generic...

SINOWAY Newsletter July, 2024 ☆ Sinoway news and Market information 1. CPHI Worldwide will be held from Oct. 08th to 10th, 2024 in Milan. And Sinoway team will be there to meet our oversea clients, share new products/technology/market information, explore new opportunities/projects ect. by face to f...

SINOWAY Newsletter June, 2024 ☆ Industry news and Sinoway Comments 1. The 2024 edition of CPhI China has ended on 21.06.2024. CPHI China is Asia’s leading pharmaceutical show. It draw 3,500+ exhibitors and 90,000+visits from the pharmaceutical industry. As usual, we shared the booth E1D57 with our 3...

We Sinoway Industrial co., ltd. will paticipate CPhI South East Asia 2024 (CPhI SEA 2024) during July 10-12. Please feel free to contact us as follow, we hope to take the face-to-face chance to share the current market situation, and exchange ideas on how to explore more possibilities in pharma...

CPHI China 2024 event is one of the foremost global events in the pharmaceutical industry. As a exhibitor for more than 20 years, Sinoway Industrial co., ltd. attended this event from June 19-21, 2024, at the Shanghai New International Expo Centre (SNIEC) in China. Our booth number is E1D57. Si...

SINOWAY Newsletter May, 2024 ☆Market information 1. The global market of synthetic biology continues to grow According to the "China Synthetic Biology Industry White Paper 2024", the global synthetic biology market has grown from US$5.3 billion in 2018 to over US$17 billion in 2023, with an average ...

CPhI Japan 2024 was held successfully in Tokyo from April 19th-21st. As an exhibitor at CPhI Japan for over 20 years, this time, we shared our advanced technologies(e.g.flow-chemistry,bio-synthesis, etc) and high-quality products, especially, some advantaged APIs and intermediates which were develop...